Not applicableNo Longer AvailableNCT00063791What this trial is testingAssess Two Different Strategies of Combining Dexamethasone and VELCADEWho this might be right forMultiple Myeloma Millennium Pharmaceuticals, Inc.
Not applicableUnknownNCT04439513What this trial is testingDual Artery Compression vs. Radial Artery-Only Hemostasis: Impact on Radial Artery Occlusion (EASY-RAO)Who this might be right forRadial Artery Injury Olivier F. Bertrand 100
Testing effectiveness (Phase 2)WithdrawnNCT00004040What this trial is testingMonoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After ChemotherapyWho this might be right forLeukemiaMultiple Myeloma and Plasma Cell Neoplasm Hoag Memorial Hospital Presbyterian
Not applicableStudy completedNCT02953002What this trial is testingThe Correlation Between The New Sepsis Scores - SOFA, Quick SOFA and Calibrated Automated Thrombogram ValuesWho this might be right forSepsisCoagulopathy HaEmek Medical Center, Israel 200
Not applicableLooking for participantsNCT06546137What this trial is testingNational Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Unified Health System Through a Multicenter RegistryWho this might be right forCardiomyopathy, HypertrophicCardiomyopathy, DilatedCardiomyopathy Restrictive+11 more Hospital do Coracao 1,211
Testing effectiveness (Phase 2)Looking for participantsNCT04661137What this trial is testingSelinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple MyelomaWho this might be right forMultiple Myeloma Hackensack Meridian Health 96
Early research (Phase 1)Looking for participantsNCT05780034What this trial is testingAC676 for the Treatment of Relapsed/Refractory B-Cell MalignanciesWho this might be right forRelapsed/Refractory B-cell Malignancies Accutar Biotechnology Inc 60
Early research (Phase 1)Study completedNCT01567709What this trial is testingAlisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell LymphomaWho this might be right forAdult B Acute Lymphoblastic LeukemiaAdult T Acute Lymphoblastic LeukemiaAnaplastic Large Cell Lymphoma+32 more National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT00869232What this trial is testingUARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete RemissionWho this might be right forMultiple Myeloma University of Arkansas 90
Early research (Phase 1)Study completedNCT00060645What this trial is testingSafety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)Who this might be right forTumorsLymphomaMultiple Myeloma Merck Sharp & Dohme LLC 33
Testing effectiveness (Phase 2)Study completedNCT00003572What this trial is testingTotal-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic CancersWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Not applicableStudy completedNCT01496781What this trial is testingEndoClot for Hemostasis and Preventing Post-procedure Bleeding After Endoscopic Mucosal ResectionWho this might be right forEndoscopic HemostasisColonic Polyps Xijing Hospital of Digestive Diseases 164
Testing effectiveness (Phase 2)Study completedNCT01989598What this trial is testingTrametinib and Akt Inhibitor GSK2141795 in Treating Patients With Relapsed or Refractory Multiple MyelomaWho this might be right forRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma National Cancer Institute (NCI) 25
Not applicableStudy completedNCT05306587What this trial is testingDaratumumab Provided at Home Experience An Open, Single-center, Mixed-method Project.Who this might be right forMultiple Myeloma Thomas Lund 40
Testing effectiveness (Phase 2)WithdrawnNCT03841565What this trial is testingDaratumumab, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple MyelomaWho this might be right forRecurrent Plasma Cell Myeloma Academic and Community Cancer Research United
Testing effectiveness (Phase 2)Study completedNCT01160107What this trial is testingRevlimid And Prednisone Followed By Revlimid, Melphalan And Prednisone In Multiple Myeloma PatientsWho this might be right forMultiple Myeloma Fondazione EMN Italy Onlus 46
Not applicableStudy completedNCT01270009What this trial is testingRole of BCL-B in Multiple MyelomaWho this might be right forMultiple Myeloma Centre Hospitalier Universitaire de Nice 60
Not applicableStudy completedNCT00408681What this trial is testingLithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more Fred Hutchinson Cancer Center 20
Not applicableStudy completedNCT04236063What this trial is testingRehabilitation Needs of the Malaysian Haematological Cancer SurvivorsWho this might be right forHaematological MalignancyLeukemia, AcuteLymphoma+3 more University of Malaya 168
Testing effectiveness (Phase 2)Study completedNCT00003887What this trial is testingLymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Fred Hutchinson Cancer Center